Life Sciences Blog
As Seen In
Tawazun was originally conceived as an inducement for investment in industrial ventures in the UAE inclusive of an offset program for development in non-military and non-hydrocarbon sector that would contribute to the diversification >
Services
Region
Industries
- Agriculture
- Corporate & Business
- Crossborder Trade & Investment
- Dispute Resolution
- Employment & Labor
- Energy & Natural Resources
- Environmental
- Financial Services
- Government & Public Sector
- Healthcare & Pharmaceuticals
- Hospitality, Media & Leisure
- Industrial & Manufacturing
- Insurance
- Life Sciences
- Real Estate & Construction
- Retail & Distribution
- Taxation
- Technology
- Telecommunications
- Transportation
Recent Posts
- Blog: Ireland IP & Technology Law BlogEDPB Publishes Annual Report for 2018Posted on July 17, 2019 by Davinia BrennanThe European Data Protection Board (EDPB) has published its Annual Report covering the period from 25 May – 31 December 2018. It provides an overview of the EDPB’s activities last year, and discusses the areas it intends to focus on in 2019-2020. Key Statistics We have set out below a summary of the key statistics from...Continue Reading…
- Blog: Waller Law BlogHealth care fraud and abuse enforcement overview 2018Posted on July 16, 2019 by Jesse C. Neil,Justin R. Hickerson
- Blog: Homeostasis: Dykema's Health Care Law BlogDevelopments in Michigan Controlled Substance Regulation: New MAPS Communication CapabilitiesPosted on July 16, 2019 by Kathleen A. ReedNEW MAPS Capabilities. The Michigan Department of Licensing and Regulatory Affairs (“LARA”) announced the launch of two new communication capabilities in MAPS, available on July 18, 2019: Read More › Tags:
- Blog: Biologics BlogFederal Circuit Invalidates Polynucleotide-Labeling Claims for Lack of EnablementPosted on July 15, 2019 by In Enzo Life Sciences v. Roche Molecular Systems, No. 2017-2498, 2017-2499, 2017-2545, 2017-2546, Slip op. (Fed. Cir. July 5, 2019), the Federal Circuit affirmed summary judgment of invalidity for lack of enablement of Enzo’s two patents relating to non-radioactive labeling of polynucleotides. The decision highlights non-enablement issues that may arise with respect to broad functional [...]
- Blog: EndpointsExperienced Health Care and Privacy Partner Join’s Verrill Dana’s Health Care GroupPosted on December 13, 2018 by Academic and Clinical Research GroupWe are pleased to welcome attorney Nadine Peters to our nationally-recognized Health Care Group. Nadine comes to Verrill Dana with more than 15 years of experience as a health care and privacy attorney and focuses on clients within the health care and life sciences industries. Most recently, Nadine served as Deputy General Counsel at the Patient-Centered Outcomes Research Institute (PCORI), an independent non-profit organization authorized under the Affordable Care Act to fund comparative effectiveness research. Prior to PCORI, she was [...]
